SAN FRANCISCO -- Immunex Corp. will tell doctors its popular rheumatoid arthritis drug Enbrel can treat other joint and spinal disorders, part of a strategy to expand the market for Enbrel and keep it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback